JAC-Antimicrobial Resistance
短名 | JAC. Antimicrob. Resist. |
Journal Impact | 3.90 |
国际分区 | PHARMACOLOGY & PHARMACY(Q2) |
ISSN | 2632-1823 |
h-index | 22 |
涉及主题 | 生物医学化学微生物学遗传学生物化学抗生素古生物学地质学细菌抗生素耐药性内科学有机化学重症监护医学病理政治学抗菌剂法学心理学外科抗菌管理计算机科学护理部 |
出版信息 | 出版商: Oxford University Press,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2019,原创研究文献占比: 0.00%,自引率:N.A., Gold OA占比: 0.00% |
平均审稿周期 | 网友分享经验:16 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018–22
2024-9-3
Genomic epidemiology and longitudinal sampling of ward wastewater environments and patients reveals complexity of the transmission dynamics of <i>bla</i>KPC-carbapenemase-producing Enterobacterales in a hospital setting
2024-9-3
Nephrotoxicity associated with aminoglycoside therapy in paediatrics: experiences from a leading referral hospital in Kenya
2024-9-3
Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing <i>Escherichia coli</i> bloodstream isolate exhibiting reduced susceptibility to both agents at baseline
2024-9-3
The imperative of teamwork in antimicrobial stewardship (AMS) interventions: insights from an ethnographic study with practitioners in Spain
2024-9-3
Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant <i>Acinetobacter baumannii</i> infections
2024-9-3
Stop antibiotics when you feel better? Opportunities, challenges and research directions
2024-9-3
The use of dual β-lactams to restore susceptibility of <i>Mycobacterium avium</i> complex
2024-9-3
Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemia
2024-9-3
P21 A one-two punch? Investigating the potential of phage–antibiotic combination (PAC) therapy using pleurotin and phage K in <i>Staphylococcus aureus</i>
2024-8-1
P13 Systematic review assessing the impact of using McIsaac and Centor scores to aid antibiotic prescription decision making in patients presenting to secondary care with pharyngitis
2024-8-1
P30 Evaluation of the hepatotoxic effect of unreasonable antibiotic therapy among patients in the pre-jaundice period of viral hepatitis A
2024-8-1
P17 Characteristics of pathogens and their susceptibility to the main groups of antibiotics in purulent-inflammatory diseases of soft tissues and post-operative purulent complications
2024-8-1
P19 Impact of the introduction of the EUCAST 2020 susceptibility interpretation rules for <i>Pseudomonas aeruginosa</i> on selection of antibiotic therapy
2024-8-1
P20 An evaluation of high oral bioavailability antibiotic prescriptions in Forth Valley Royal Hospital
2024-8-1
P25 Pharmacovigilance assessment of Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with antibacterial drugs using FDA adverse event reporting system data
2024-8-1
P11 Pharmacists’ knowledge, attitudes and perceptions towards antimicrobial stewardship and resistance during the COVID-19 pandemic at secondary care settings in the UK
2024-8-1
P05 A targeted antimicrobial pharmacy technician ward service improves stewardship and patient-centred care and safety of commonly prescribed higher risk antimicrobials in the acute hospital setting
2024-8-1
P32 Bloodstream infection following transrectal ultrasound-guided prostate biopsy: antibiotic susceptibility of isolates relative to perioperative antibiotic prophylaxis regimen
2024-8-1
P26 Exploring socioeconomic disparities effect on patient understanding of antimicrobial resistance: a Southwest Devon study
2024-8-1
P23 Advance market commitment for point of care diagnostic focused on neonatal sepsis: estimating costs and effectiveness
2024-8-1
P18 Uncovering the role of secondary messenger signalling in <i>Acinetobacter baumannii</i> virulence
2024-8-1
P07 Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA): results on critical care patients from a multinational, multicentre, observational analysis
2024-8-1
P27 Investigation of subtherapeutic vancomycin levels
2024-8-1
P02 Evaluating the impact of antimicrobial stewardship interventions in a UK paediatric emergency department
2024-8-1
P35 Impact of IV to oral antibiotic switch optimization on nurse time and plastic waste at the Royal Cornwall Hospital Trust
2024-8-1
P29 Understanding penicillin allergy assessment and delabelling massive open online community
2024-8-1
P15 The main aetiological factors of lung damage in severe pneumonia and sepsis in military servicemen: retrospective analysis for 2023
2024-8-1
O04 UKHSA Start Smart Then Focus antimicrobial stewardship: effective implementation during the COVID-19 pandemic at an NHS Foundation Trust in the UK
2024-8-1
P37 Molecular characterization of resistance and heteroresistance to cefiderocol in clinical Gram-negative isolates
2024-8-1
O03 Scale and spread of a quality improvement initiative promoting metronidazole IV to oral switch (IVOST) in the acute hospital setting: antimicrobial stewardship, patient safety, workforce and environmental sustainability benefits
2024-8-1
P03 An evaluation of Antibiotic Champions events in GP practices in Cambridgeshire and Peterborough Integrated Care System
2024-8-1
P36 Improving AMS programmes for paediatric services via a shared post working collaboratively across five hospital trusts within South Yorkshire
2024-8-1
P14 Knowledge, attitude and practices on antibiotic usage and resistance among people attending primary healthcare in Rwanda
2024-8-1
O01 Antimicrobial resistance and death certification: are we there yet?
2024-8-1
P38 Re-assessment of the primary efficacy outcomes of cefepime/enmetazobactam versus piperacillin/tazobactam in adult patients with complicated urinary tract infections or acute pyelonephritis using updated EUCAST piperacillin/tazobactam susceptibility breakpoints
2024-8-1
P28 An analysis of the appropriateness of antimicrobial prescribing at a tertiary centre: reflections from the National Point Prevalence Survey
2024-8-1
P12 Clinical perceptions of the need for anaerobic coverage in patients treated for aspiration pneumonia (AP)
2024-8-1
P06 Management challenges and treatment options of difficult-to-treat organisms in patients with complex medical devices: a case of vancomycin-resistant <i>Enterococcus</i> infection in a patient with a left ventricular assist device
2024-8-1
P16 Analysis of antibiotic resistance in wounded servicemen with infectious complications
2024-8-1
P04 Surgical antibiotic prophylaxis adherence: before and after antimicrobial stewardship team impact in a south Indian secondary care hospital
2024-8-1
P08 Antimicrobial drug efficacy in surgical site infections post soft tissue augmentation: an analytic review
2024-8-1
O02 Beyond borders: a global risk analysis of XDR <i>Salmonella</i> Typhi and typhoid outbreaks in Pakistan
2024-8-1
P34 Hospital clinician knowledge, opportunity and motivation to prescribe short course antibiotic therapy for common infections
2024-8-1
P09 Genomic characterization of nasal <i>Enterococcus faecalis</i> carrying linezolid resistance in healthy hosts identifies zoonotic transmission
2024-8-1
P01 Assessment of risk factors associated with MDR organism infections among patients admitted in a tertiary hospital—a retrospective study
2024-8-1
P24 Antimicrobial susceptibility profiles of hypervirulent strains of <i>Clostridioides difficile</i> of pig and human origin
2024-8-1
P22 How do we improve gentamicin prescribing and reviewing within colorectal wards—a quality improvement project
2024-8-1
P33 Improving compliance with early IV-to-oral switch of antibiotics using quality improvement methodology
2024-8-1
P31 An observational prospective audit on the use of vancomycin and ciprofloxacin in the treatment of severe community-acquired pneumonia in penicillin-allergic patients in NHS Lothian
2024-8-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远